There is the good news of coronavirus vaccine trials to be conducted in India. Pharma major Dr. Reddy’s Laboratories and Russia’s sovereign wealth fund RDIF have received approval from the Drugs Controller General of India (DCGI) to conduct an adaptive phase 2/3 human clinical trial for the Sputnik V vaccine in the country.

Coronavirus Pandemic: Clinical trials for Sputnik V to resume and to be held in India

pharma-major-dr-reddys-laboratories

Pharma Major Dr. Reddy’s Laboratories, News on Pharma Major Dr. Reddy’s Laboratories, stories on Pharma Major Dr. Reddy’s Laboratories, articles on Pharma Major Dr. Reddy’s Laboratories, Pharma Major Dr. Reddy’s Laboratories stories at Wion, Pharma Major Dr. Reddy’s Laboratories news, Pharma Major Dr. Reddy’s Laboratories latest news

pharma major-dr-reddys-laboratories

Coronavirus Pandemic: Clinical trials for Sputnik V to resume and to be held in India